DIN 02533472 — HADLIMA 40 MG
HADLIMA is a solution of Adalimumab marketed by SAMSUNG BIOEPIS CO., LTD. The full Adalimumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02533472
- Brand name
- HADLIMA
- Active ingredient
- Adalimumab
- Strength
- 40 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- SAMSUNG BIOEPIS CO., LTD
- Health Canada status
- MARKETED
- Drug class
- Tumor necrosis factor (TNF)-alpha inhibitor / biologic response modifier
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Adalimumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02511061 | ABRILADA | 20 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02511045 | ABRILADA | 40 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02511053 | ABRILADA | 40 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02459299 | AMGEVITA | 50 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02459302 | AMGEVITA | 50 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02459310 | AMGEVITA | 50 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02473097 | HADLIMA | 40 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02473100 | HADLIMA PUSHTOUCH | 40 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02533480 | HADLIMA PUSHTOUCH | 40 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02502380 | HULIO | 20 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02502399 | HULIO | 40 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02502402 | HULIO | 40 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02474263 | HUMIRA | 20 MG | SOLUTION | ABBVIE CORPORATION | MARKETED |
| 02258595 | HUMIRA | 40 MG | SOLUTION | ABBVIE CORPORATION | MARKETED |
| 02458349 | HUMIRA | 40 MG | SOLUTION | ABBVIE CORPORATION | MARKETED |
| 02458357 | HUMIRA | 40 MG | SOLUTION | ABBVIE CORPORATION | MARKETED |
| 02505258 | HYRIMOZ | 20 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02542315 | HYRIMOZ | 20 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02492156 | HYRIMOZ | 40 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02492164 | HYRIMOZ | 40 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02542323 | HYRIMOZ | 40 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02542331 | HYRIMOZ | 40 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02542358 | HYRIMOZ | 80 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02542366 | HYRIMOZ | 80 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02502674 | IDACIO | 40 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02502682 | IDACIO | 40 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02523949 | SIMLANDI | 40 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02523957 | SIMLANDI | 40 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02523965 | SIMLANDI | 80 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02523760 | YUFLYMA | 40 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02523779 | YUFLYMA | 40 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02535076 | YUFLYMA | 80 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02535084 | YUFLYMA | 80 MG | SOLUTION | CELLTRION INC. | MARKETED |